Literature DB >> 25749826

Higher levels of reactive oxygen species are associated with anergy in chronic lymphocytic leukemia.

Adam Linley1, Beatriz Valle-Argos2, Andrew J Steele2, Freda K Stevenson2, Francesco Forconi3, Graham Packham2.   

Abstract

Entities:  

Keywords:  ROS; anergy; chronic lymphocytic leukemia; reactive oxygen species

Mesh：

Substances：

Year:  2015        PMID： 25749826      PMCID： PMC4486238          DOI： 10.3324/haematol.2014.120824

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine.

Authors:  J S Carew; S T Nawrocki; R H Xu; K Dunner; D J McConkey; W G Wierda; M J Keating; P Huang
Journal:  Leukemia       Date:  2004-12       Impact factor: 11.528

2.  Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status.

Authors:  C Ian Mockridge; Kathleen N Potter; Isla Wheatley; Louise A Neville; Graham Packham; Freda K Stevenson
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

3.  The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro.

Authors:  A J Steele; D T Jones; K Ganeshaguru; V M Duke; B C Yogashangary; J M North; M W Lowdell; P D Kottaridis; A B Mehta; A G Prentice; A V Hoffbrand; R G Wickremasinghe
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

4.  Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia.

Authors:  Jelena Tomic; Brian Lichty; David E Spaner
Journal:  Blood       Date:  2011-01-04       Impact factor: 22.113

5.  Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells.

Authors:  J Nilsson; O Söderberg; K Nilsson; A Rosén
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

6.  HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species.

Authors:  Melania Capasso; Mandeep K Bhamrah; Tom Henley; Robert S Boyd; Claudia Langlais; Kelvin Cain; David Dinsdale; Karen Pulford; Mahmood Khan; Boris Musset; Vladimir V Cherny; Deri Morgan; Randy D Gascoyne; Elena Vigorito; Thomas E DeCoursey; Ian C M MacLennan; Martin J S Dyer
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

7.  Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents.

Authors:  Yan Zhou; Elizabeth O Hileman; William Plunkett; Michael J Keating; Peng Huang
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

8.  Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications.

Authors:  J S Carew; Y Zhou; M Albitar; J D Carew; M J Keating; Peng Huang
Journal:  Leukemia       Date:  2003-08       Impact factor: 11.528

9.  Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.

Authors:  Dunyaporn Trachootham; Hui Zhang; Wan Zhang; Li Feng; Min Du; Yan Zhou; Zhao Chen; Helene Pelicano; William Plunkett; William G Wierda; Michael J Keating; Peng Huang
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

10.  Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cells.

Authors:  Carlo Calissano; Rajendra N Damle; Sonia Marsilio; Xiao-Jie Yan; Sophia Yancopoulos; Gregory Hayes; Claire Emson; Elizabeth J Murphy; Marc K Hellerstein; Cristina Sison; Matthew S Kaufman; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Ivana Ivanovic; Igor M Dozmorov; Sergio Roa; Matthew D Scharff; Wentian Li; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2011-09-23       Impact factor: 6.354
View more
  2 in total

1.  The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia.

Authors:  Marilisa Galasso; Elisa Dalla Pozza; Roberto Chignola; Simona Gambino; Chiara Cavallini; Francesca Maria Quaglia; Ornella Lovato; Ilaria Dando; Giorgio Malpeli; Mauro Krampera; Massimo Donadelli; Maria G Romanelli; Maria T Scupoli
Journal:  Cell Mol Life Sci       Date:  2022-09-16       Impact factor: 9.207

2.  Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia.

Authors:  Walaa Darwiche; Cathy Gomila; Hakim Ouled-Haddou; Marie Naudot; Cécile Doualle; Pierre Morel; Florence Nguyen-Khac; Loïc Garçon; Jean-Pierre Marolleau; Hussein Ghamlouch
Journal:  J Exp Clin Cancer Res       Date:  2020-10-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.